about
Polycystic ovarian syndrome: Social situation influences outcome.Serum testosterone levels in male hypogonadism: Why and when to check-A review.Role of capillary ketone testing in the diagnosis and monitoring of diabetic ketoacidosis.Clinical appropriateness of C-reactive protein requests: Reduction in unnecessary repeats.Polycystic ovarian syndrome: Assessment of approaches to diagnosis and cardiometabolic monitoring in UK primary care.The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17Reduction of unnecessary N-terminal pro-brain natriuretic peptide (NT-proBNP) tests: A further lesson in demand managementDemographic factor clustering at a GP practice level in England and its relation to glycaemic outcomes: What we can learn from thisHypogonadism is not being sufficiently recognised in 99% of general practices/family doctor surgeriesReal-world practice level data analysis confirms link between variability within Blood Glucose Monitoring Strip (BGMS) and glycosylated haemoglobin (HbA1c) in Type 1 DiabetesPatient perception of support within primary care is as important as medication and services in achieving good glycaemic control
P50
Q47727976-975B4FB8-E28C-46BD-9C15-95BEE8487127Q48239845-A1C3A7B9-53C7-4818-B16F-3A4FE6E5401EQ48316343-70E2FFED-08FE-40A2-A121-6821D2E87582Q48330148-568AD1E1-E041-4A52-902A-03E3AB697C66Q48357864-9135058D-A1C9-4321-8DC5-F24B69BDB0FFQ88051116-419E1A16-DC7B-4DC3-B892-D81B8658AB3FQ89023332-8F794934-FBB1-4F15-A55C-1913241BCE48Q90266868-2C2E2080-234B-4FC2-8F5F-95951362A1E0Q91241365-A121031A-57E3-43C1-849A-B132846AC376Q91247776-EFA0C5B0-53F4-4A6A-91A6-F9B9B221295DQ91593127-432C42CC-D3BD-45DC-B8D0-C83B647AC999
P50
description
researcher
@en
name
Mark Livingston
@en
type
label
Mark Livingston
@en
prefLabel
Mark Livingston
@en
P31
P496
0000-0001-6878-0769